Act Capital Management, LLC Anavex Life Sciences Corp. Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$9.74 - $17.69 $326,290 - $592,615
-33,500 Closed
0 $0
Q4 2021

Feb 03, 2022
SELL
$16.88 - $23.31 $624,560 - $862,470
-37,000 Reduced 52.48%
33,500 $581,000
Q3 2021

Nov 16, 2021
BUY
$16.82 - $25.75 $1.19 Million - $1.82 Million
70,500 New
70,500 $1.27 Million

Others Institutions Holding AVXL

# of Institutions
155
Shares Held
27.3M
Call Options Held
515K
Put Options Held
838K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $847M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email